Overview: Mounjaro 2.5mg Solution for Injection is prescribed to manage blood sugar levels in adults with type 2 diabetes. It is used alongside diet and exercise to improve glycemic control. Key Benefits: – Helps in significant reduction of blood sugar – Supports weight management in diabetic patients – Once-weekly injectable formulation Composition: Each pre-filled pen contains: Tirzepatide 2.5mg How It Works: Tirzepatide is a dual GIP and GLP-1 receptor agonist. It enhances insulin secretion, lowers glucagon levels, and slows gastric emptying, leading to better glucose regulation. Usage Directions: – Administer subcutaneously once weekly, on the same day each week – Can be injected in the abdomen, thigh, or upper arm – Follow your physician’s dosage instructions carefully Possible Side Effects: – Nausea and vomiting – Decreased appetite – Diarrhea or constipation – Injection site reactions – Risk of hypoglycemia (especially with other antidiabetics) Precautions: – Not for use in type 1 diabetes or diabetic ketoacidosis – Inform doctor if pregnant or breastfeeding – Regular blood glucose monitoring is essential Storage Instructions: – Store between 2°C and 8°C in a refrigerator – Do not freeze – Keep out of reach of children Manufacturer: Eli Lilly and Company India Pvt Ltd Disclaimer: This information is for educational use only and should not replace professional medical advice. Please consult your doctor for guidance regarding your health.